The Cuban medicine Heberprot-P will be applied in Kuwait
- Submitted by: Camila
- Health and Medicine
- 11 / 16 / 2014
The Center for Genetic Engineering and Biotechnology (CIGB) of Cuba will perform a program to implement medication Heberprot-P in the treatment of diabetic foot ulcers in the State of Kuwait.
The ambassador of this country in Cuba, Bader Al - Awadi, met with the CEO of CIGB, Luis Herrera, and other members of the institution, for details related to the tests with the new drug for the treatment of ulcer diabetic foot, which will be held soon in Kuwait.
The program for the application of this drug in Kuwaiti territory have the cooperation of the Institute Dasman Diabetes care in this country.